Happy you've got it all wrong. It is AZ's trial with AZ's drug. SPL have provided Dep and it's the Dep part which is touted to bring in the $2.4B which to me is just typical JF fairy tale talk just like the $1.75B BV market where we appear to have cornered a couple of hundred thousand max of that which they will not disclose. They won't disclose how much income is coming from BV treatment because she claims it's commercially sensitive. What BS!
The only reason it's "commercially sensitive" is because it's an embarrassment.
Webinar this Friday 8th April with Jackie Fairley, page-38
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.5¢ | $12.55K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 586785 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 56840 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |